Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lot Quality Assurance Sampling | 8 | 2015 | 17 | 2.830 |
Why?
|
Disease Outbreaks | 13 | 2021 | 1747 | 1.500 |
Why?
|
Schistosoma mansoni | 3 | 2012 | 156 | 0.850 |
Why?
|
Schistosomiasis mansoni | 2 | 2012 | 94 | 0.780 |
Why?
|
Cluster Analysis | 8 | 2015 | 2706 | 0.680 |
Why?
|
Space-Time Clustering | 2 | 2009 | 45 | 0.640 |
Why?
|
Quality Assurance, Health Care | 5 | 2015 | 2165 | 0.620 |
Why?
|
Sentinel Surveillance | 3 | 2011 | 291 | 0.620 |
Why?
|
Program Evaluation | 5 | 2018 | 2487 | 0.620 |
Why?
|
Poliomyelitis | 2 | 2018 | 92 | 0.570 |
Why?
|
Population Surveillance | 6 | 2014 | 2599 | 0.570 |
Why?
|
Influenza, Human | 4 | 2013 | 1521 | 0.530 |
Why?
|
Parasite Egg Count | 2 | 2012 | 29 | 0.530 |
Why?
|
Basic Reproduction Number | 2 | 2021 | 36 | 0.530 |
Why?
|
Sampling Studies | 2 | 2015 | 615 | 0.520 |
Why?
|
Drug Resistance, Viral | 2 | 2013 | 862 | 0.490 |
Why?
|
Entropy | 1 | 2015 | 210 | 0.480 |
Why?
|
Bayes Theorem | 2 | 2013 | 2327 | 0.480 |
Why?
|
Data Interpretation, Statistical | 4 | 2013 | 2691 | 0.460 |
Why?
|
HIV-1 | 4 | 2015 | 6851 | 0.410 |
Why?
|
Mass Vaccination | 1 | 2014 | 109 | 0.410 |
Why?
|
Data Collection | 3 | 2014 | 3319 | 0.400 |
Why?
|
Tuberculosis, Pulmonary | 4 | 2016 | 830 | 0.390 |
Why?
|
Crime Victims | 1 | 2015 | 347 | 0.370 |
Why?
|
Health Surveys | 3 | 2015 | 4036 | 0.360 |
Why?
|
Computer Simulation | 9 | 2018 | 6225 | 0.340 |
Why?
|
Public Sector | 2 | 2012 | 264 | 0.330 |
Why?
|
Influenza A Virus, H1N1 Subtype | 2 | 2012 | 447 | 0.330 |
Why?
|
Biostatistics | 1 | 2011 | 164 | 0.320 |
Why?
|
HIV Infections | 6 | 2015 | 17349 | 0.320 |
Why?
|
Tuberculosis, Multidrug-Resistant | 5 | 2016 | 934 | 0.320 |
Why?
|
Immunization | 1 | 2013 | 1218 | 0.310 |
Why?
|
Epidemiologic Methods | 1 | 2013 | 1336 | 0.300 |
Why?
|
Topography, Medical | 1 | 2007 | 37 | 0.300 |
Why?
|
Firearms | 1 | 2015 | 626 | 0.290 |
Why?
|
Disease Transmission, Infectious | 1 | 2013 | 561 | 0.290 |
Why?
|
Leukemia | 2 | 2014 | 1518 | 0.290 |
Why?
|
Research Design | 2 | 2021 | 6178 | 0.280 |
Why?
|
Health Care Surveys | 1 | 2014 | 2424 | 0.270 |
Why?
|
Sample Size | 3 | 2015 | 841 | 0.260 |
Why?
|
Health Status Indicators | 1 | 2011 | 970 | 0.250 |
Why?
|
HIV | 1 | 2012 | 1581 | 0.250 |
Why?
|
Epidemiologic Measurements | 1 | 2004 | 23 | 0.240 |
Why?
|
Models, Statistical | 6 | 2015 | 5077 | 0.230 |
Why?
|
Prevalence | 10 | 2022 | 15717 | 0.230 |
Why?
|
Drug Resistance, Bacterial | 1 | 2010 | 1048 | 0.210 |
Why?
|
Decision Support Techniques | 1 | 2012 | 2000 | 0.200 |
Why?
|
Health Status | 1 | 2015 | 4077 | 0.200 |
Why?
|
Delivery of Health Care | 2 | 2018 | 5333 | 0.190 |
Why?
|
DNA, Viral | 1 | 2007 | 2195 | 0.170 |
Why?
|
Infant, Very Low Birth Weight | 2 | 2002 | 407 | 0.170 |
Why?
|
Anti-HIV Agents | 2 | 2013 | 4526 | 0.170 |
Why?
|
Humans | 52 | 2022 | 761098 | 0.170 |
Why?
|
Phylogeny | 1 | 2007 | 2809 | 0.160 |
Why?
|
Antitubercular Agents | 3 | 2016 | 1375 | 0.160 |
Why?
|
Infant, Premature, Diseases | 2 | 2002 | 710 | 0.160 |
Why?
|
Pandemics | 3 | 2020 | 8663 | 0.160 |
Why?
|
Statistics as Topic | 1 | 2005 | 2359 | 0.150 |
Why?
|
Evolution, Molecular | 1 | 2007 | 1882 | 0.150 |
Why?
|
Infant, Extremely Low Birth Weight | 2 | 2009 | 83 | 0.150 |
Why?
|
Algorithms | 6 | 2015 | 14023 | 0.150 |
Why?
|
New York | 2 | 2014 | 875 | 0.150 |
Why?
|
Likelihood Functions | 2 | 2013 | 991 | 0.140 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2002 | 497 | 0.140 |
Why?
|
Models, Genetic | 1 | 2007 | 3430 | 0.140 |
Why?
|
Mass Screening | 1 | 2012 | 5425 | 0.140 |
Why?
|
Chronic Disease | 2 | 2011 | 9317 | 0.130 |
Why?
|
Echoencephalography | 3 | 2008 | 134 | 0.130 |
Why?
|
Infection Control | 2 | 2015 | 983 | 0.130 |
Why?
|
Environmental Exposure | 1 | 2011 | 4479 | 0.130 |
Why?
|
Morbidity | 1 | 2021 | 1750 | 0.130 |
Why?
|
Sensitivity and Specificity | 4 | 2015 | 14676 | 0.120 |
Why?
|
Ventilation | 1 | 2015 | 128 | 0.120 |
Why?
|
Geographic Information Systems | 2 | 2014 | 281 | 0.120 |
Why?
|
Rifampin | 1 | 2016 | 338 | 0.120 |
Why?
|
Prenatal Care | 1 | 2022 | 1141 | 0.110 |
Why?
|
Florida | 1 | 2015 | 429 | 0.110 |
Why?
|
Cerebral Palsy | 2 | 2009 | 477 | 0.110 |
Why?
|
Local Government | 1 | 2014 | 81 | 0.110 |
Why?
|
Disinfection | 1 | 2015 | 207 | 0.110 |
Why?
|
Child Health Services | 1 | 2018 | 644 | 0.110 |
Why?
|
Residence Characteristics | 2 | 2015 | 2092 | 0.100 |
Why?
|
Africa, Eastern | 1 | 2012 | 76 | 0.100 |
Why?
|
Measles Vaccine | 1 | 2013 | 79 | 0.100 |
Why?
|
United Nations | 1 | 2013 | 148 | 0.100 |
Why?
|
Regression Analysis | 2 | 2015 | 6343 | 0.100 |
Why?
|
Anthelmintics | 1 | 2012 | 83 | 0.100 |
Why?
|
Cerebral Hemorrhage | 2 | 2009 | 2642 | 0.100 |
Why?
|
Health Services Research | 1 | 2018 | 1807 | 0.090 |
Why?
|
Models, Theoretical | 2 | 2015 | 3568 | 0.090 |
Why?
|
Total Quality Management | 1 | 2012 | 262 | 0.090 |
Why?
|
South Africa | 2 | 2013 | 1843 | 0.090 |
Why?
|
Nigeria | 1 | 2014 | 771 | 0.090 |
Why?
|
Uganda | 1 | 2015 | 1332 | 0.090 |
Why?
|
Micronutrients | 1 | 2013 | 381 | 0.090 |
Why?
|
Mosquito Nets | 1 | 2010 | 8 | 0.090 |
Why?
|
Ultraviolet Rays | 1 | 2015 | 1079 | 0.090 |
Why?
|
Chemoprevention | 1 | 2012 | 325 | 0.090 |
Why?
|
Culex | 1 | 2009 | 18 | 0.090 |
Why?
|
Cost Control | 1 | 2012 | 627 | 0.090 |
Why?
|
Costs and Cost Analysis | 1 | 2015 | 1664 | 0.080 |
Why?
|
Developmental Disabilities | 2 | 2009 | 1510 | 0.080 |
Why?
|
Masks | 1 | 2012 | 208 | 0.080 |
Why?
|
West Nile Fever | 1 | 2009 | 75 | 0.080 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2013 | 369 | 0.080 |
Why?
|
Insect Vectors | 1 | 2009 | 136 | 0.080 |
Why?
|
Infant, Newborn | 8 | 2022 | 26187 | 0.080 |
Why?
|
Health Personnel | 1 | 2022 | 3335 | 0.070 |
Why?
|
Uncertainty | 1 | 2013 | 752 | 0.070 |
Why?
|
Incidence | 3 | 2015 | 21357 | 0.070 |
Why?
|
Urban Population | 1 | 2015 | 2035 | 0.070 |
Why?
|
Infant | 5 | 2018 | 36164 | 0.070 |
Why?
|
Child | 6 | 2018 | 80134 | 0.070 |
Why?
|
Child, Preschool | 6 | 2018 | 42217 | 0.070 |
Why?
|
Cleft Lip | 1 | 2012 | 506 | 0.070 |
Why?
|
Gastrointestinal Tract | 1 | 2013 | 834 | 0.070 |
Why?
|
Software | 1 | 2021 | 4433 | 0.070 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2008 | 113 | 0.070 |
Why?
|
Cleft Palate | 1 | 2012 | 589 | 0.070 |
Why?
|
Folic Acid | 1 | 2013 | 1323 | 0.070 |
Why?
|
Demography | 3 | 2009 | 1643 | 0.070 |
Why?
|
Vaccination | 1 | 2018 | 3368 | 0.070 |
Why?
|
Iron | 1 | 2013 | 1790 | 0.060 |
Why?
|
Rural Population | 1 | 2015 | 2277 | 0.060 |
Why?
|
Birth Weight | 1 | 2013 | 2101 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2013 | 15308 | 0.060 |
Why?
|
Sputum | 2 | 2016 | 505 | 0.060 |
Why?
|
Male | 12 | 2016 | 360675 | 0.060 |
Why?
|
Computer Systems | 1 | 2005 | 470 | 0.060 |
Why?
|
India | 1 | 2010 | 2287 | 0.060 |
Why?
|
Psychomotor Performance | 2 | 2009 | 1881 | 0.050 |
Why?
|
Confidentiality | 1 | 2007 | 607 | 0.050 |
Why?
|
Female | 15 | 2022 | 392458 | 0.050 |
Why?
|
Head | 1 | 2009 | 922 | 0.050 |
Why?
|
Weight Gain | 1 | 2013 | 2349 | 0.050 |
Why?
|
Selection Bias | 1 | 2004 | 359 | 0.050 |
Why?
|
Anti-Retroviral Agents | 1 | 2012 | 1784 | 0.050 |
Why?
|
Tuberculosis | 1 | 2015 | 2015 | 0.050 |
Why?
|
Bioterrorism | 1 | 2003 | 144 | 0.050 |
Why?
|
Triplets | 1 | 2002 | 42 | 0.050 |
Why?
|
Guinea Pigs | 2 | 2015 | 1309 | 0.050 |
Why?
|
ROC Curve | 1 | 2010 | 3582 | 0.050 |
Why?
|
Patient Admission | 1 | 2009 | 1365 | 0.050 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2009 | 845 | 0.050 |
Why?
|
Decision Making | 1 | 2015 | 3925 | 0.050 |
Why?
|
Alleles | 1 | 2012 | 6857 | 0.050 |
Why?
|
Brain Damage, Chronic | 1 | 2002 | 266 | 0.050 |
Why?
|
Chorioamnionitis | 1 | 2002 | 156 | 0.040 |
Why?
|
Leukomalacia, Periventricular | 1 | 2002 | 184 | 0.040 |
Why?
|
Twins | 1 | 2002 | 340 | 0.040 |
Why?
|
Computational Biology | 2 | 2013 | 3499 | 0.040 |
Why?
|
Malaria | 1 | 2010 | 1225 | 0.040 |
Why?
|
Adult | 8 | 2016 | 221083 | 0.040 |
Why?
|
Neutrophil Infiltration | 1 | 2002 | 390 | 0.040 |
Why?
|
Public Health | 1 | 2013 | 2671 | 0.040 |
Why?
|
History, 20th Century | 1 | 2008 | 2764 | 0.040 |
Why?
|
Monte Carlo Method | 1 | 2005 | 1257 | 0.040 |
Why?
|
Gestational Age | 1 | 2008 | 3577 | 0.040 |
Why?
|
Animals | 6 | 2015 | 168083 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10213 | 0.040 |
Why?
|
Brain Diseases | 1 | 2008 | 1546 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 26068 | 0.040 |
Why?
|
Adolescent | 4 | 2015 | 88271 | 0.040 |
Why?
|
Madagascar | 1 | 2018 | 109 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2007 | 4109 | 0.040 |
Why?
|
Microbial Sensitivity Tests | 2 | 2016 | 1936 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2021 | 64670 | 0.040 |
Why?
|
Respiratory Tract Infections | 1 | 2005 | 1009 | 0.040 |
Why?
|
Child Development | 1 | 2008 | 2302 | 0.030 |
Why?
|
Fetal Diseases | 1 | 2002 | 912 | 0.030 |
Why?
|
Massachusetts | 1 | 2009 | 8836 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2007 | 4739 | 0.030 |
Why?
|
Immunization Programs | 1 | 2018 | 267 | 0.030 |
Why?
|
Hypotension | 1 | 2002 | 879 | 0.030 |
Why?
|
Placenta | 2 | 2002 | 1709 | 0.030 |
Why?
|
Genetic Variation | 2 | 2009 | 6565 | 0.030 |
Why?
|
Neurologic Examination | 2 | 2009 | 915 | 0.030 |
Why?
|
Tuberculin Test | 1 | 2015 | 206 | 0.030 |
Why?
|
Uzbekistan | 1 | 2013 | 1 | 0.030 |
Why?
|
Bread | 1 | 2013 | 23 | 0.030 |
Why?
|
Flour | 1 | 2013 | 21 | 0.030 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2016 | 628 | 0.030 |
Why?
|
Mycobacterium tuberculosis | 2 | 2016 | 1913 | 0.030 |
Why?
|
Pregnancy | 4 | 2022 | 29872 | 0.030 |
Why?
|
Folic Acid Deficiency | 1 | 2013 | 117 | 0.030 |
Why?
|
Organization and Administration | 1 | 2012 | 54 | 0.030 |
Why?
|
Food, Fortified | 1 | 2013 | 189 | 0.030 |
Why?
|
Stomach Neoplasms | 1 | 2002 | 1458 | 0.020 |
Why?
|
Lung Diseases | 1 | 2002 | 1909 | 0.020 |
Why?
|
Surgical Procedures, Operative | 1 | 2003 | 1923 | 0.020 |
Why?
|
Models, Biological | 1 | 2007 | 9455 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2016 | 1702 | 0.020 |
Why?
|
Malawi | 1 | 2012 | 300 | 0.020 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2012 | 361 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2002 | 2920 | 0.020 |
Why?
|
Critical Care | 1 | 2003 | 2690 | 0.020 |
Why?
|
Retreatment | 1 | 2012 | 598 | 0.020 |
Why?
|
Treatment Failure | 1 | 2016 | 2643 | 0.020 |
Why?
|
Mozambique | 1 | 2010 | 55 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2003 | 3743 | 0.020 |
Why?
|
Neutrophils | 1 | 2002 | 3763 | 0.020 |
Why?
|
Insecticide-Treated Bednets | 1 | 2010 | 67 | 0.020 |
Why?
|
Middle Aged | 5 | 2016 | 220835 | 0.020 |
Why?
|
Private Sector | 1 | 2012 | 394 | 0.020 |
Why?
|
Risk Factors | 2 | 2014 | 74219 | 0.020 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2012 | 251 | 0.020 |
Why?
|
Peru | 1 | 2012 | 888 | 0.020 |
Why?
|
Young Adult | 1 | 2015 | 59199 | 0.020 |
Why?
|
Certification | 1 | 2012 | 418 | 0.020 |
Why?
|
CD-ROM | 1 | 2008 | 24 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 4014 | 0.020 |
Why?
|
Mutation | 1 | 2013 | 30006 | 0.020 |
Why?
|
Hemiplegia | 1 | 2008 | 136 | 0.020 |
Why?
|
Hemoglobins | 1 | 2013 | 1525 | 0.020 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2012 | 585 | 0.020 |
Why?
|
Microsatellite Repeats | 1 | 2009 | 782 | 0.020 |
Why?
|
Logistic Models | 1 | 2002 | 13254 | 0.020 |
Why?
|
Risk Assessment | 2 | 2014 | 24013 | 0.020 |
Why?
|
United States | 3 | 2009 | 72337 | 0.020 |
Why?
|
Quadriplegia | 1 | 2008 | 226 | 0.020 |
Why?
|
Feces | 1 | 2013 | 1490 | 0.020 |
Why?
|
Cohort Studies | 3 | 2016 | 41486 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6482 | 0.020 |
Why?
|
Benchmarking | 1 | 2012 | 1045 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2003 | 5427 | 0.020 |
Why?
|
Gene Frequency | 1 | 2012 | 3603 | 0.020 |
Why?
|
Risk | 1 | 2016 | 9614 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10755 | 0.010 |
Why?
|
Microcephaly | 1 | 2008 | 425 | 0.010 |
Why?
|
Canada | 1 | 2009 | 2125 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2927 | 0.010 |
Why?
|
Geography | 1 | 2005 | 652 | 0.010 |
Why?
|
Public Health Administration | 1 | 2005 | 242 | 0.010 |
Why?
|
Cost of Illness | 1 | 2012 | 1937 | 0.010 |
Why?
|
Ureaplasma | 1 | 2002 | 60 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2012 | 20120 | 0.010 |
Why?
|
Infant, Premature | 2 | 2002 | 2106 | 0.010 |
Why?
|
Bacteria | 1 | 2013 | 2190 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12467 | 0.010 |
Why?
|
Medical History Taking | 1 | 2005 | 773 | 0.010 |
Why?
|
Brain | 2 | 2012 | 27097 | 0.010 |
Why?
|
Patient Care Team | 1 | 2012 | 2513 | 0.010 |
Why?
|
Respiration, Artificial | 2 | 2002 | 2630 | 0.010 |
Why?
|
Italy | 1 | 2002 | 843 | 0.010 |
Why?
|
Calibration | 1 | 2003 | 819 | 0.010 |
Why?
|
Appointments and Schedules | 1 | 2003 | 442 | 0.010 |
Why?
|
Motor Activity | 1 | 2009 | 2712 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2002 | 12058 | 0.010 |
Why?
|
Genotype | 1 | 2012 | 12983 | 0.010 |
Why?
|
Gastrectomy | 1 | 2002 | 671 | 0.010 |
Why?
|
Vasodilator Agents | 1 | 2002 | 989 | 0.010 |
Why?
|
Registries | 1 | 2012 | 8236 | 0.010 |
Why?
|
DNA | 1 | 2009 | 7189 | 0.010 |
Why?
|
Ultrasonography | 1 | 2009 | 5971 | 0.010 |
Why?
|
Health Services Needs and Demand | 1 | 2003 | 1401 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2002 | 2913 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2005 | 2769 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2008 | 39121 | 0.010 |
Why?
|
Hospitals, Pediatric | 1 | 2003 | 1860 | 0.010 |
Why?
|
Inflammation | 1 | 2013 | 10758 | 0.010 |
Why?
|
Comorbidity | 1 | 2008 | 10514 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 12670 | 0.010 |
Why?
|
Prospective Studies | 2 | 2012 | 54419 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12975 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2003 | 1921 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2012 | 80673 | 0.010 |
Why?
|
Cognition | 1 | 2008 | 6987 | 0.010 |
Why?
|
Time Factors | 1 | 2012 | 39953 | 0.010 |
Why?
|
Boston | 1 | 2003 | 9324 | 0.010 |
Why?
|
Survival Analysis | 1 | 2002 | 10083 | 0.010 |
Why?
|
Sex Factors | 1 | 2002 | 10552 | 0.000 |
Why?
|
Survival Rate | 1 | 2002 | 12727 | 0.000 |
Why?
|
Pregnancy Complications | 1 | 2002 | 2948 | 0.000 |
Why?
|
Sepsis | 1 | 2002 | 2586 | 0.000 |
Why?
|
Emergency Service, Hospital | 1 | 2005 | 7873 | 0.000 |
Why?
|
Age Factors | 1 | 2002 | 18385 | 0.000 |
Why?
|
Case-Control Studies | 1 | 2002 | 22157 | 0.000 |
Why?
|
Prognosis | 1 | 2002 | 29672 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 36418 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2002 | 58946 | 0.000 |
Why?
|
Aged | 1 | 2002 | 169266 | 0.000 |
Why?
|